Alcon's Q4 Earnings Miss Estimates, Stock Falls, Revenues Rise Y/YZacks Investment Research • 02/25/26
Alcon (ALC) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/25/26
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate SalesBusiness Wire • 02/24/26
Gear Up for Alcon (ALC) Q4 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 02/19/26
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World's Only Monthly Multifocal Toric Contact Lens with Water Gradient TechnologyBusiness Wire • 02/17/26
Alcon Debuts Groundbreaking PRECISION7 in Canada, a One-Week Replacement Contact Lens to Start and End Every Week FreshBusiness Wire • 02/02/26
Alcon Inc. (ALC) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to AlconBusiness Wire • 01/06/26
Staar Surgical to reject Alcon takeover bid after failing to win shareholder backingReuters • 01/06/26
Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to AlconBusiness Wire • 12/19/25
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of StockholdersBusiness Wire • 12/19/25
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.PRNewsWire • 12/17/25
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction FailsBusiness Wire • 12/17/25
STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder ValueBusiness Wire • 12/17/25
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon TransactionBusiness Wire • 12/16/25
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to AlconBusiness Wire • 12/16/25
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to AlconBusiness Wire • 12/12/25
Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to AlconBusiness Wire • 12/11/25